Why the study?
Cardiac myxoma diagnosis is often elusive and advanced cardiac imaging is not widely available, motivating evaluation of ortho-Positronium as a novel diagnostic biomarker.
Does ortho-Positronium (o-Ps) imaging differentiate cardiac myxoma from normal tissue in perioperative samples?
Does ortho-Positronium (o-Ps) imaging differentiate cardiac myxoma from normal tissue in perioperative samples?
Ortho-Positronium (o-Ps) lifetime analysis shows potential as a novel nanoscale imaging biomarker for differentiating cardiac myxoma from normal tissue.
No takes yet. Share an insight, caveat, or question.
o-Ps imaging may aid CM diagnosis where CT/MRI unavailable; hypothesis-generating and requires prospective validation before clinical adoption.
Moskal et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: